{"ticker": {"uuid": "b6b1c62f-53df-40d4-917b-28f92e61ffbe", "symbol": "ASTRAZEN", "name": "AstraZeneca Pharma India Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-07-16T12:46:47+00:00", "published_display": "16 Jul 2026 12:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQajQtQUd4QTdEZkxVeV9fQkRodGxKM1FKMXJ1ZGxTa056NTdPR09kRHRETVB6ZFVvTHNZQzI0RVZEM2NDN1RmTE1PbjdRYmJrdHFuV2xTS2lOeEVvT3lEcnlIMU9reW8wbXVxXzRkejZmVGp3Snk5d1hhOGJkZ0dETi1yS1ZNQ3BQQ2VjNEY5MnfSAZYBQVVfeXFMTUViakhPaDlVZFVHdXNpNjQ5SDZzNFV2SDB2MmoySlFWOTBUT202QTZMN3pneVdqUjkyUVBhNFJ3T3pLT0MzekJFZnBaSmdSYzcxVGFBWmJmZEFfbDhUSUx2U1d6aDZXOXBzT3VlWWJWUm5FaERJZ1JSMDhFSDNZR0JNS1RteTZndzMybDh2cU1NZWNNV2ZB?oc=5", "source_name": "CNBC", "published_at": "2026-07-11T05:00:01+00:00", "published_display": "11 Jul 2026 05:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNUnpDUUJnMU1RV2xmZGZ5WGVVYkkwcnlkeEZWMTdhdncydFZGRFlFVmVYd2E2Ui1nMklFOVI0VmRKdVFocXdid0hDV1h3RVRLaEZsekNXdXh3ZnRvZHVHbmV2S0Z3WnFMa2RWbzAzTV9uT1FrVThHLThJb1pDT0tzbk1ianhnNGFxQ09wSUdKM01FaFBGWVg0cFpZQ0pDQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:15:05+00:00", "published_display": "10 Jul 2026 22:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lumentum, Sandisk, Applied Materials, AstraZeneca, and More Stocks That Explain Today\u2019s Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTFB4UzktMVNXS2R0SjFvUFVaSHJRUXBVSElSVFhFUHFlZE96RGJYUVlsV0FNMEFRUXlZX2t5V3lOUXlIU3ZmMjJLNm5GSVVIOEpQRUN6cVdXcGtMZzluamw2OXRSUDE?oc=5", "source_name": "Barron's", "published_at": "2026-07-09T20:47:00+00:00", "published_display": "09 Jul 2026 20:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOc1lPYXlqVWlSVHYwaV8xLTM0M1paYi1nRUJmRUtTa20tUkdoVHY4amZGU2VmNXAtY0syX2xyOGRvZDBjbDRyeU45RFROMmY2TW9rbTI0TWJjZ3dqWklxNFo5MmZVd3d3V1FRa3hnN0ZfZ2lGTFdYTkxieGZVeHZnSXEtckRfaDhyUFJ1UzdURk9HejJWeWM2ZXVheXp3cWNF?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-09T20:26:00+00:00", "published_display": "09 Jul 2026 20:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's Wainua fails key heart disease trial, shares tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNT1hfTDNWX2IwRHVtOFA5eGxKRWNuWjJOT3Vyd04yUXViOWRGUWxUMmxOVl9fZmV3Z0c4X3BpV2FrVFhRUHg2T1JRMDVaTndpZEZ6WnJ5SXo3c1l5N3BsTXphblBhOENEbG5ueUpxNFl3LUlWMGZXYkduaHNVZ0c3N0JqZTh4dWVpWTNDaUpHdFV6WWpVUUcxTHJfR2x6dHVvTl9KdW9GbVctTFFxbXEwMTdLQVBpQ3Y5dzE3RXdfczNYaDBCLUtMbGJRM0NvU2V3bE9LMlcyNGtpazF5Y21r?oc=5", "source_name": "Reuters", "published_at": "2026-07-09T16:05:39+00:00", "published_display": "09 Jul 2026 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca and Ionis\u2019 stocks drop significantly on Wainua ATTR-CM trial failure", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPUmhSbmRKVVJQbVRmMmxRd2cteDZoeHdabjEwR0FMdDVtaVVtdXdsQmlJVS1jSG1VMGFSbHBGRnBLcEpuX0lhN3ljZU9ILTZxX09KT2RyTlFKTklkWnMtX2ZiRk1ZbmxfUlN6clR6QlMyYzduandhQ09CWmtTbE52R3d0dFNnVS03YXc5blA1WEpvc3otNUszbHprclV2T3IxOEZwVUJ2VkcyRG1xeFB0bDVYMGRRMUp2UmZ0bHJn?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-09T15:59:22+00:00", "published_display": "09 Jul 2026 15:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock drops 9% after Wainua heart drug trial fails", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPSmtTMjB5UEx6WWpYTUk1dXEtX1hxTTFyRXZaWVFwd2I4cV82dEVxYU9hOW1uSXk0bE5xbGV4X2N4dk41dmRiLV9yLW1oN3JGTU9TMmxuN3l4UWQwUU1uV09zWDF6Vk5jUzRYbDNDREJOenprQTZpemlnYUN1U2RLYzNzbUwtaE1LakFuRDdxM3hTUkdsSUVR?oc=5", "source_name": "qz.com", "published_at": "2026-07-09T14:40:05+00:00", "published_display": "09 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca, Ionis Shares Slide After Wainua Misses Target in Heart Disease Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPU0dSaVRkN2pmY3lURW10RzVwYlRRNFFfcW90Vmg3SVRiUXFpTG1ON25fdWNsR1ZJdXNJS3NSQ1gwYVdNaDhfRzlZTnRyTGY0M1l6UGxQS1BrZnQxZTN4bE1rak1zNGJtMzRMcUVCbVlzWVlmTHBWeXdxb01iVFJtZWFGbTJkeGczVk12Y2NHbTVvd25VZ01mQnhtM0l6OF81VUE?oc=5", "source_name": "WSJ", "published_at": "2026-07-09T13:41:00+00:00", "published_display": "09 Jul 2026 13:41", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca and Ionis Stock Slump After Trial Miss Is an Overreaction", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQU3Zla2lxdExtVXVweTBJclR3MldqOXN4bV8zZ0RIa1c2Q0ZDRng4Sm5SVHhvS2dJYUpCR2ZiMmUxcVVmMFhIeGZsUmpwTW81MURLUUJPVVZoSWRRZG5aOHpIWmw4MGNxbXJUMnk0Q0Q2T3NLRDY3MVVrMTdyT1ctOE5vaDFSZVMzVHlYaVNLVFM?oc=5", "source_name": "Barron's", "published_at": "2026-07-09T11:38:00+00:00", "published_display": "09 Jul 2026 11:38", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca sees stock market value slump by more than \u00a320bn after drug setback", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOZGI1U2FSaVAtR3ZYQXUwaVZUTkxRQlU3cFpuUmV3elBNN3FZS1VtTEdQdEkteXpEX19PQ3pSdnBuS1VYbTAwNnBQQmxhNlhUSFRubkJvV0JreGU4ZUdFeklKVFExcGpPX3daNkxSTnJXcGNfZGVYVmZJWlViRFZxN2dOZ3pMQXVaRWduMA?oc=5", "source_name": "Market source", "published_at": "2026-07-09T10:30:46+00:00", "published_display": "09 Jul 2026 10:30", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's \u00a319bn blow as Wainua heart drug fails key late-stage trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPVUNRS0NMb3JOTEw2dy1IdHRjR1JSZHA2YkVUaUlYSG03cmg4dVlzX09WeXg2QmF4N2VtaWxoaVBZTEVfVHNpc2s0enZYTUdEVVFUWXBsNUM4UHVHc2hKb1FMWHVRS0RuWUtfQkpLZ1B6MF9pOXkzY0RnM3RCMEZKLU9QS1RBdGRGWUdnbg?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:50:00+00:00", "published_display": "09 Jul 2026 07:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPMDQyN2hzSzZrYVFOY3F1RUtzSENYRlUyZk5zaHBZVERYQVY1V0UwN2thZXNqQW5vdXctUFR4emVhVjdSaGt0WjdIMFMwZ1A3LXYzczFpWkJ5TDIxd0E4RGNfYzR1SndVU3lXcm9yUFhZT0c5MExOM0xkRjl5VGJjSS1NN2jSAYoBQVVfeXFMT1J2UFFLZ2huendrTThlUnVkTU4zUHFMd3dfMVJyYmxSSVNaanBmbFNELTVGMjZuVGlnWk1sQThWMmlaVUNZTFBNblRGWTBSb1NGeXBacW9hamlGNjFKZnB5V2VmMlVfYjRsQjlZdkZJM2RxUGpHX0MyMXJmUTM0ZGtzWVlEZ2RtcVhn?oc=5", "source_name": "CNBC", "published_at": "2026-07-09T07:34:08+00:00", "published_display": "09 Jul 2026 07:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca shares slide after heart treatment disappoints in trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOa1p5Z3NZMU50QTkydjZMYkJOMS1aSmt2X2x1MHJBdWh6UGRIekplSjJ6eVN2OUpTQ0ExTGZseXVMVVFCWmxZTkx1TTltUXVNNzRQbUpFQklia1lJZGV1QjhBaWtrY2tGOFhib2hJaHFpQlRYemo3djBPX1lPc2JHNGZMenA?oc=5", "source_name": "Financial Times", "published_at": "2026-07-09T07:20:22+00:00", "published_display": "09 Jul 2026 07:20", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNa1ExMXdlbkdyNGFqa0hlX0FscGlseTUwZTU3N1lMVWFzQWxYYXRuQUl2aEwxOGNQeHBmOEZGdHNaS1ltYTl2QVdJNnZnWXlsZERpQlhUc2dWMFFuZ1BMd0hvSGNQOEozRno1Vm9jZ0xNbUpsMWVObk1fLUI5SWJkUjBYQUNBczZBbFZ2YWNYM2VHQnpXVXB2bFVMdTQxUHRu?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Ltd appoints Mihir Parikh, Amay Ashok Pandey as Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOd01QQ2VENTFaQTEzWHQxTUZuOHQ0a1RSb2hwNFlVcFF3QnY0MGxkQ1lFczVfZWEzUWFIbE5KOGtiQ3Q1Q1E1SzFuallNSmo1bzVhajNUS3hRb2U2Ujc4SGlSaV9QdHdjcHpoZ01HRC1heXpkelJnNGJYZmI0SXBMMWstaDhpMnp2TTN5YnBCNkQwdUtRYXNPdkZ2bEREaWlXUGpsY0JLRkZHeUhOYXBHSkJlZVhzZ2pVZ2JLNVpkQUJZVlJYNVBGZWNBZHE?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOYzJ1VmltcFhibVVwU0stc19wdXd3Z0tKdU1wTUFrcjEzeTI2RnhHc3gxX3YybVZJSVBhQmVreldvLU9SeHVmLTNTTjU0WlpZSDA0aWtzWFhzWW1RS01VYzJTUE5DUDM4RGFtZWFrcWQ1NnFWakZuZUw0VTA4WWFxRWg1X3l0Y2hDZEQ1ZzZNNkFFT1R2ZlYyLVFwUHk?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNalVkSVBsa1oyTE1DU25VZjlQNWNrWkFTOFRFMEItWjFzaThNMk92WkRydTVCbnBhOFdCUGN0LU1TYUFyd0RfQml6eWdzM1YtV3BGdGZnQ1h6cHlMd1R2U2FtREI4dXhyTktUWW0xNmVXM1lWTzhlN2tleTN2UWktMmNXclE2SWFoT3NZVnh0emctblFYU2c?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQdFRlQ1h2eDM0VHYwa253dVlmYmdfeFBnX2s2VkVtS3RLZU5NZVBsbWs5NDVLaVRFakFhTW91QUVTTU4zM2VYSjc0Q0Exc191TGZoM0xsVnlYaGZUTzZIR0hmZmFlUU1VdFdZejR5TXdoRklwVFlLZnlSeG9Xa1ZiT1pYekZKX2pnX011MzAzS0R2ekpVaW83empGb045NUFLU0E?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxONEc1MDVPTEd1SEt4ZHZxVUlPYWpjcFRBbUY1V2hOZzk5VVZyU09TTjdFQjdDSGhzV1pTTHl3TVloOXJSWC1VTUJSUEFnY0gtdThNQk9BRXgzUEZJZWZKOFhDLWJ5c3N0bkczZUVteGtGeWVFQXNvcjgzeks5MkFQY2pMbHgzbEVCQmk0eWozMjZaOE1ibkE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India closes trading window until Q1FY27 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOWHRfMy01M3lCUkQ5UE5jakFzbFEwZVZGUGdMSDdCc1VCeWdsQ19PcElPREJadmJfT1c1cGZHa1V3ekZoQnpCMGx0aTNKR1A2NFE5SGJnTGR0QWJVUnlvNHoyUkRkWk8za3hqdHl3VzRaOTlhU1BhblNucDFSRjhZUzY3UHFiTGRXTTdRdUtTclhGZlBweUdUNlZXRk5jTVhCdFo3WDVFbUNRS2NiQmtmd3lhc1RYVXFVc1ozZmlB?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India accepts resignations of two senior executives", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZU10dnA0b1luaVA4NGRQMkZZSk1QRFVKQjJzUmxob29XaWFBQ0lGOEtqeWdHOXRDdUpCOGVaVUNKQmR6OWNURGpuTXpiUU1idzg5SHlud0FudEk0djk2V1VqR0pWNXRnVFZ2d2E5RzBWazM3S2l2UkVOQVYyYWx3d0xyN29hQktBMXdDaTh1UzZOQ0dDZ0s2YzhBUHNZcGRXMU5OckVMb05WdnpVN2ZpMnJHVWFHU1BvMzZDNQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think That There Are Issues Underlying AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPckdQVjl4bG42U2pRdHVXRk5mOFVNODdOS3puV2RkRElnQlJ1VTRFWlpkdjBTSElxcmI0dkZucVBQVnR5SjhKWDNJLW5CT3dKczFOSnBCdlNVb0k3dFJxaUJpZzFMem0tb2RqdFJncFUtMzJKdm55RWc0ZWJOTERLY0hBMU1DXy1sY28xX3FSQWVCQVZWY0xOT2EzU0tWM1BCLU5JNWFwaHhSZGk5RU1lY0hDN3l5RzVISnVTTVlIT2RjTW05dzFReGdUQ2VrbnhGS3NyTmFEMkdycjJNVEN0RUk5V2pPYTFfUXdZNWpJTFlucFMzNzl0MHFn0gH_AUFVX3lxTE1wOUZTQS1JQ2dFbUhoQ3o3ZUJSbU4yZ2FFT19Qb183RWFiTnNUYXVzRy1QWVZoREY1OXhhTEcwaktWcXZCRmRDcHhGNDIzajlXblgtTGlFQmlDSjlLbk9qemQzemkwa0FqN0FKajUwRFNBSW1QZndZZzYtRW94enVBVEZ3X3FfS2NNcWlPa0ZJaFhQenZ3M3JnSy1Xbk9SUXBCME4xSVJ6bHphMWFDc08wYW5BWW5oUmVyWnUzWmZTQWVxMnh0M3ljbGFWWl94WjdON0hmM21zaVlOampyMHZuSG84VnhNSi1LTXRwVUdYcFZGLXF3V0x0QVlIVU9BMA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why AstraZeneca Pharma India (NSE:ASTRAZEN) Has Caught The Eye Of Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQTGNrV3lfQlduQ1N6VjNhNndNV3owT0V5d0dISE4wMi1PRDNMSDEydnZMRGRPWkV6Um5PZkh2dE8xcExzZi1GS3doZXIwTnlEU01jSTJRWXBzTERhcWFrdDd3TkdmT3BRekMwQUdSWlUtak5ybnJ6ZkRNeHBOdXVpdW9DNjktcmJtdWxzRGsyVnp6U1J1WmdSOU15LUJrNEtzR3o0NXBNcWtPeURucmkyQ3NlQmlwN1A5M1VENmxZSk9NYnFyN3FlNUNuWU5iR3FxUXhTWWdCc1kxMXE2M0x4UkVtNzgtd3RHVk1USzFDXzR3ZDRPZEFqNFB30gH_AUFVX3lxTFBHWTlNOXFtSHMwelZsVW1GY0gyQkdWenpEU1ZWNjFSbFdDbUhIa1IyQUNEQW80XzJCTWR4N2p3VmhIaV9ScE5YeFRoUmtVU3dmeWRBWTlGdHo5WG1Od1ZTS3RIeHY0dHVWUnpEb1dYeVlYR2lHRDl2aTFxQmVBQk5RYnRZZ3dSRFR4YnNTXzVsZjFnMWlvNnB4T1BvbUNjQl9fbHhoaktCR0w2bVVILS0wVmo2QXI1V1ZpTnktV2w4UmVZLTNiV2ZOMHhaRG9FcG9zN3JiN2ZuY1R6cGVkZ1NaWnMzREs5UW5QeGtlTExCa2thcmpwRWgtQnJpYzRNOA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca Pharma Q4 Profit Drops 23% to \u20b944.9 Cr as Margins Shrink to 10.5%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdDFaMkVFX1JSVUpzX2hVV3N2NF9aU0QzdnQxV3RVRHREa18tX0dFRFQ2THBQQ1cwN0ZqalZ1SjUxdHpTbGVrOHEwaGp4SENGd2xjbExjNmVSVGJNS3BuOWFHbXQ0bGZTTjg3RjJNTFRTa2FIVklqWkhhc2w4NmVxLXB4cmNGa1FoellFZThVa28zNVEzTFpiYnRMZUlneExDeHhkcEs4YjloVVFMblUwTmpOQQ?oc=5", "source_name": "Sahi", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Falls 7% on Q4 Profit Drop, Margin Hit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVlhlWnZzS29hU1NLQy12MGJBQy1kRHRjYVRQaEhQeFdrTkJMVjBtcjJiSGZwSDBQQVVyY0FFd0xNOEdBS3M0NUI3alhwT01qY0s2QkVER3VPODR3S1JiTEk1TFJMSm9uT2hkQ2ViaUsteDE1YU1Zd1BveGp0VEI1eU95bHpDUmxtR1ZZM3pOblV1SktDODVTTFQ3N1pvcUhwR251Y0t1MVZqOXZqczdFSmowVDRkTS1sdElv?oc=5", "source_name": "HDFC Sky", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma shares slip 6% on posting 23% fall in Q4 profit YoY", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca FY26 revenue rises 33%, recommends \u20b936 dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZW9SampvTEloa2praHBzVWtjWUJtZG9iUkhlcV9yMENENzhKMXl4UjYwdnFDaTM2aURXMGRlOHFyOEFjcXRaS3dtWWdBbl83MDRSdklVZDhoSmxVc0ZzblN5ZTM2NWFiQjVpeFpZamxlT2tHR21BZEdFcUl6eDhLOERodHlCdElJQVRwemQ0bzRKRnhueFBGaHVJNzhFNjBDcUxOb0lyVnZJODdlWEYzTGxLSGhtbGsx?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca falls 7% as Q4 net profit declines 23%; here's a trading strategy for the pharma stock", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Q4 profit drops 23% despite strong revenue growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma Q4 Profit Drops 23% to \u20b944.9 Cr Despite 20.8% Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPQkxVUlF6bXljMkpqWTdhOHRUWEQtNTI2TGdmU2tjTVdwRXpsNFRLcFRmMEZuUHlEZWpvQTNCaWtUT3lfWWh4enM1V2U5TDVZZ2VNcVRYS3RVZHMyYkhYMzV6SHhaek9qMmVmUC1lYjRWV1FiRWVlZDR3OHpadjhXRlNNbUg3dmVWOUVXU0FxOTJJdE1nUVlSUHJhUWpQS3JQUUtFSXB0Q1lMOUVLclU4YlZJWDc?oc=5", "source_name": "Sahi", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India's Revenue Boost Amid Profit Dip", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQeXpwT1k0OWI4WngzTUF6Sjc3eTY3TTRaWG5MLTNacWVRTGtIX0JvQ2pCbEEtQ3R2Njg1WDJzcGhQM2o2OUNHeXMxRmpfSkF3MjhZVmVvOS1tYUlQMC1BWXhkNVZYaEpRdWI2MXdpRUhVOWZCY2EyWnNMcVBEUzlxZVlVWUtwMXNmLWc0V0lfZnNBSVlUWjdqT1A2THpJSi00SHVZWUh0RndBOWvSAbABQVVfeXFMT2huRDZRRHd4eEx5ci1LUGlIdUozTk8zMU9RZkt1Y2swektfcjVjLTNBOGh2Y3lDbWRKZEpZYjJuRDVGM214NkpXeGF6OFItZHJBQ2RUNGt5SHNPb0R1djBNOVVzZHhOWHhsVGp0VG5wQl9oTl9aSmswbGtFT2xfaC1fWUZyeThRY01KRmt4TkRzLTNlUmdKYjNpTHdwaml3NlBhUnZiZ1BuYWRuNk1Jblk?oc=5", "source_name": "Devdiscourse", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxNcVlCdldmODQxWWs3ZWtFS3JLTWNkZjNoNDh5M0VqZ3RzcFp2YkhzaUpDLWVyWkltTklKMnZVQ0JDeXFkeDBnYUJ0eFRmc2FPRktOc3lTdGd1dDh4UXZzakU4djBGRlZIUm8zYXNOdmdiOFJNQ3MwT3JEbGZod0M0ajdKZW5iSHc3S010YUF3MDlGNGdPajJhNGtoeGJhQm50VV8zYWhNWnRVQkRpVXFzRWowMGQ3NG1teUJjTTFhTDhNVldJNG9qQUlNZF9GX1NnekVVdUJIRXg3RmdaT01WYjdQYUNRWEszd1hzdjFOTQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock falls after FDA panel votes against new cancer drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNYWQ4cWdTbU1Bekl1LVhWZjMtSjZFY2N3OGk1YlRzaXZiUkI1TVlJNm85Uk9iY0N2WmFwQkZiVW9aTEc0ZHhhUkRQalhkZ3ViNWx5TWhQcjNyMVpIWWJpNWlOb1Y2dUJRQTBQOXFsaVVNc3ljVC15ZnZzZVlFTWxUMnh0VGpXQdIBiwFBVV95cUxOb2JzdjJacWh4bE9nalhqcDJtNlVpVW1SZ1p2djJoSWt5NG8ycjhLejZOVmZPR1JmejJ3RjF4eUNIQ2c3STRZNFRuNTBFTktPOFpRMEREY2ZmT3I5aVZTSW9jOXVpOUtlWmczTmVYc3ZVM0hoakYwOHpSRldjRXBOMFdlRHBINVpxMC1F?oc=5", "source_name": "CNBC", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch Today: Swiggy, Enviro Infra, Advait Energy, AstraZeneca, Torrent Pharma, Laxmi Organic,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) market cap surged \u20b98.0b last week, public companies who have a lot riding on the company were rewarded", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOdjRreUE2U1VSSEQ0VEprY25EM0pqX001Rm5IUmpaQ0tmdmVrcFNlbEJ4M1ppY0Q1Y1RIQ0k0VlI4YWhFREtJdnJCV25mUzlFYlhDeTNIUFNEYldJSTUyZzh4UXdTdFhRNGhyWHpEMmVndzRMXzRaaGhTWG5oZzdBMFNNLTVFUUo4UVlUX29YTVRRbkdJeDVUT1RZTjFLYVRxVHZfdlVmeFVlV2tiNGRyUEZvbkliQWhITkNvcDhYMXV4MnFYcXN6UGt1QUVWcHZQS0t4ZXNkbTVSVm84WnJXOFRBcW9uNmJJclJ4c3RMTTFZNWZjU05RZExn0gH_AUFVX3lxTE9BWGI2dlEyb1dESVh5S3g2cDV3R2FoNG9SdUs4LXc1YkVoX2gtTnhfTEEwdGc0OE5taUN1MHRpYUl0ajN4LUVtY0o5UUI0OE13T2hib2pidVRSeWs5aVNVTG9hbW5CRXBhQkZ5OExxbVE1QWFNVjdfTTh5T0NhRDEzWkpwTDlMd3I5QV9qNG10RGVCako5dThFaWxScUJ4VE8zN1hDNFp0MDA1aWFodXV2S3lGQ2xfMVZHTkJCY0hNT2VzWDNtUUFhV0tjZ1l1Wm5Qc0dFQTVUbmdwaTBLLUhVTmowYW5qQ0ViV0RVLVBFTmVwaV9ySnRxUjJNeURzdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPMWtuQzczY3ltajY4cUdBOVJGcEdDcXN1Nk12RVhwWU9MYXFvYzc1ckpZeHB3bnFlQ1A2OG01S3lTUDJqQUdEYUVXS2FpTXBudVdYTC1aX2I0MGRUdVNSMzBJRGZtTnM3YTNXcXp0eEVWaEpJb1E0TTlWY2J5VjNSdWtjQTFIMV8ySENONTJ5MzI2ZHVvLWFjaUtpejRacWxELXc?oc=5", "source_name": "AstraZeneca", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Ltd. Share Price Today - AstraZeneca Pharma India Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOLUNvQmlGQW1rWnlaTzNnSHBkVEF4RFRWZHBPMXR6RzRwOWZNOGRwWDJPcVdhWmo0YzBsZzVPMDdmenpIRkJfWnFKeVV4R0xzMlo4Nlo1cTVzNG50QmpZMWdyTE1hVFZHVndxeXkwX2haX05jT3hFS1Q4RE5lOVdVQjhIc2RLRkVtaDJwQQ?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T08:16:25+00:00", "published_display": "03 Jan 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India shares surge over 3% on new Hyperkalaemia drug deal with Sun Pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-11-18T08:00:00+00:00", "published_display": "18 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca, exiting production digs in India, surrenders local manufacturing license", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPd0pNMWRYdGxiaUVDTkpKeDFhbTloLUNvVTVRZVpkMk5TNWpHVFNnSzlZdjRuTDdpSE1oRlVNOEcwVm1fdEFoUXRBYTYwTExQb3AwdzI1d19KM1pCY05qWE1NSWtfVWw4Y080WFZ0Z0JLVmV4RmZyTC1HaTM3b1NlTFVyWFJlSmRGeWZzOHVxTlFfQ0hKX3h4VlA3ZFRWQ1l1OHNNbXAzTjhWOFFzT0M2c2dub0JUdFJKcVJYVWJqQmo?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-09-03T07:00:00+00:00", "published_display": "03 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-07-16T12:46:47+00:00", "published_display": "16 Jul 2026 12:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQajQtQUd4QTdEZkxVeV9fQkRodGxKM1FKMXJ1ZGxTa056NTdPR09kRHRETVB6ZFVvTHNZQzI0RVZEM2NDN1RmTE1PbjdRYmJrdHFuV2xTS2lOeEVvT3lEcnlIMU9reW8wbXVxXzRkejZmVGp3Snk5d1hhOGJkZ0dETi1yS1ZNQ3BQQ2VjNEY5MnfSAZYBQVVfeXFMTUViakhPaDlVZFVHdXNpNjQ5SDZzNFV2SDB2MmoySlFWOTBUT202QTZMN3pneVdqUjkyUVBhNFJ3T3pLT0MzekJFZnBaSmdSYzcxVGFBWmJmZEFfbDhUSUx2U1d6aDZXOXBzT3VlWWJWUm5FaERJZ1JSMDhFSDNZR0JNS1RteTZndzMybDh2cU1NZWNNV2ZB?oc=5", "source_name": "CNBC", "published_at": "2026-07-11T05:00:01+00:00", "published_display": "11 Jul 2026 05:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Dips While Market Gains: Key Facts", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNUnpDUUJnMU1RV2xmZGZ5WGVVYkkwcnlkeEZWMTdhdncydFZGRFlFVmVYd2E2Ui1nMklFOVI0VmRKdVFocXdid0hDV1h3RVRLaEZsekNXdXh3ZnRvZHVHbmV2S0Z3WnFMa2RWbzAzTV9uT1FrVThHLThJb1pDT0tzbk1ianhnNGFxQ09wSUdKM01FaFBGWVg0cFpZQ0pDQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-10T22:15:05+00:00", "published_display": "10 Jul 2026 22:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lumentum, Sandisk, Applied Materials, AstraZeneca, and More Stocks That Explain Today\u2019s Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZEFVX3lxTFB4UzktMVNXS2R0SjFvUFVaSHJRUXBVSElSVFhFUHFlZE96RGJYUVlsV0FNMEFRUXlZX2t5V3lOUXlIU3ZmMjJLNm5GSVVIOEpQRUN6cVdXcGtMZzluamw2OXRSUDE?oc=5", "source_name": "Barron's", "published_at": "2026-07-09T20:47:00+00:00", "published_display": "09 Jul 2026 20:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOc1lPYXlqVWlSVHYwaV8xLTM0M1paYi1nRUJmRUtTa20tUkdoVHY4amZGU2VmNXAtY0syX2xyOGRvZDBjbDRyeU45RFROMmY2TW9rbTI0TWJjZ3dqWklxNFo5MmZVd3d3V1FRa3hnN0ZfZ2lGTFdYTkxieGZVeHZnSXEtckRfaDhyUFJ1UzdURk9HejJWeWM2ZXVheXp3cWNF?oc=5", "source_name": "Investor's Business Daily", "published_at": "2026-07-09T20:26:00+00:00", "published_display": "09 Jul 2026 20:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's Wainua fails key heart disease trial, shares tumble", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNT1hfTDNWX2IwRHVtOFA5eGxKRWNuWjJOT3Vyd04yUXViOWRGUWxUMmxOVl9fZmV3Z0c4X3BpV2FrVFhRUHg2T1JRMDVaTndpZEZ6WnJ5SXo3c1l5N3BsTXphblBhOENEbG5ueUpxNFl3LUlWMGZXYkduaHNVZ0c3N0JqZTh4dWVpWTNDaUpHdFV6WWpVUUcxTHJfR2x6dHVvTl9KdW9GbVctTFFxbXEwMTdLQVBpQ3Y5dzE3RXdfczNYaDBCLUtMbGJRM0NvU2V3bE9LMlcyNGtpazF5Y21r?oc=5", "source_name": "Reuters", "published_at": "2026-07-09T16:05:39+00:00", "published_display": "09 Jul 2026 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca and Ionis\u2019 stocks drop significantly on Wainua ATTR-CM trial failure", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPUmhSbmRKVVJQbVRmMmxRd2cteDZoeHdabjEwR0FMdDVtaVVtdXdsQmlJVS1jSG1VMGFSbHBGRnBLcEpuX0lhN3ljZU9ILTZxX09KT2RyTlFKTklkWnMtX2ZiRk1ZbmxfUlN6clR6QlMyYzduandhQ09CWmtTbE52R3d0dFNnVS03YXc5blA1WEpvc3otNUszbHprclV2T3IxOEZwVUJ2VkcyRG1xeFB0bDVYMGRRMUp2UmZ0bHJn?oc=5", "source_name": "Clinical Trials Arena", "published_at": "2026-07-09T15:59:22+00:00", "published_display": "09 Jul 2026 15:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock drops 9% after Wainua heart drug trial fails", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPSmtTMjB5UEx6WWpYTUk1dXEtX1hxTTFyRXZaWVFwd2I4cV82dEVxYU9hOW1uSXk0bE5xbGV4X2N4dk41dmRiLV9yLW1oN3JGTU9TMmxuN3l4UWQwUU1uV09zWDF6Vk5jUzRYbDNDREJOenprQTZpemlnYUN1U2RLYzNzbUwtaE1LakFuRDdxM3hTUkdsSUVR?oc=5", "source_name": "qz.com", "published_at": "2026-07-09T14:40:05+00:00", "published_display": "09 Jul 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca, Ionis Shares Slide After Wainua Misses Target in Heart Disease Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPU0dSaVRkN2pmY3lURW10RzVwYlRRNFFfcW90Vmg3SVRiUXFpTG1ON25fdWNsR1ZJdXNJS3NSQ1gwYVdNaDhfRzlZTnRyTGY0M1l6UGxQS1BrZnQxZTN4bE1rak1zNGJtMzRMcUVCbVlzWVlmTHBWeXdxb01iVFJtZWFGbTJkeGczVk12Y2NHbTVvd25VZ01mQnhtM0l6OF81VUE?oc=5", "source_name": "WSJ", "published_at": "2026-07-09T13:41:00+00:00", "published_display": "09 Jul 2026 13:41", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca and Ionis Stock Slump After Trial Miss Is an Overreaction", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQU3Zla2lxdExtVXVweTBJclR3MldqOXN4bV8zZ0RIa1c2Q0ZDRng4Sm5SVHhvS2dJYUpCR2ZiMmUxcVVmMFhIeGZsUmpwTW81MURLUUJPVVZoSWRRZG5aOHpIWmw4MGNxbXJUMnk0Q0Q2T3NLRDY3MVVrMTdyT1ctOE5vaDFSZVMzVHlYaVNLVFM?oc=5", "source_name": "Barron's", "published_at": "2026-07-09T11:38:00+00:00", "published_display": "09 Jul 2026 11:38", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca sees stock market value slump by more than \u00a320bn after drug setback", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOZGI1U2FSaVAtR3ZYQXUwaVZUTkxRQlU3cFpuUmV3elBNN3FZS1VtTEdQdEkteXpEX19PQ3pSdnBuS1VYbTAwNnBQQmxhNlhUSFRubkJvV0JreGU4ZUdFeklKVFExcGpPX3daNkxSTnJXcGNfZGVYVmZJWlViRFZxN2dOZ3pMQXVaRWduMA?oc=5", "source_name": "Market source", "published_at": "2026-07-09T10:30:46+00:00", "published_display": "09 Jul 2026 10:30", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca's \u00a319bn blow as Wainua heart drug fails key late-stage trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPVUNRS0NMb3JOTEw2dy1IdHRjR1JSZHA2YkVUaUlYSG03cmg4dVlzX09WeXg2QmF4N2VtaWxoaVBZTEVfVHNpc2s0enZYTUdEVVFUWXBsNUM4UHVHc2hKb1FMWHVRS0RuWUtfQkpLZ1B6MF9pOXkzY0RnM3RCMEZKLU9QS1RBdGRGWUdnbg?oc=5", "source_name": "Market source", "published_at": "2026-07-09T07:50:00+00:00", "published_display": "09 Jul 2026 07:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPMDQyN2hzSzZrYVFOY3F1RUtzSENYRlUyZk5zaHBZVERYQVY1V0UwN2thZXNqQW5vdXctUFR4emVhVjdSaGt0WjdIMFMwZ1A3LXYzczFpWkJ5TDIxd0E4RGNfYzR1SndVU3lXcm9yUFhZT0c5MExOM0xkRjl5VGJjSS1NN2jSAYoBQVVfeXFMT1J2UFFLZ2huendrTThlUnVkTU4zUHFMd3dfMVJyYmxSSVNaanBmbFNELTVGMjZuVGlnWk1sQThWMmlaVUNZTFBNblRGWTBSb1NGeXBacW9hamlGNjFKZnB5V2VmMlVfYjRsQjlZdkZJM2RxUGpHX0MyMXJmUTM0ZGtzWVlEZ2RtcVhn?oc=5", "source_name": "CNBC", "published_at": "2026-07-09T07:34:08+00:00", "published_display": "09 Jul 2026 07:34", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca shares slide after heart treatment disappoints in trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOa1p5Z3NZMU50QTkydjZMYkJOMS1aSmt2X2x1MHJBdWh6UGRIekplSjJ6eVN2OUpTQ0ExTGZseXVMVVFCWmxZTkx1TTltUXVNNzRQbUpFQklia1lJZGV1QjhBaWtrY2tGOFhib2hJaHFpQlRYemo3djBPX1lPc2JHNGZMenA?oc=5", "source_name": "Financial Times", "published_at": "2026-07-09T07:20:22+00:00", "published_display": "09 Jul 2026 07:20", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNa1ExMXdlbkdyNGFqa0hlX0FscGlseTUwZTU3N1lMVWFzQWxYYXRuQUl2aEwxOGNQeHBmOEZGdHNaS1ltYTl2QVdJNnZnWXlsZERpQlhUc2dWMFFuZ1BMd0hvSGNQOEozRno1Vm9jZ0xNbUpsMWVObk1fLUI5SWJkUjBYQUNBczZBbFZ2YWNYM2VHQnpXVXB2bFVMdTQxUHRu?oc=5", "source_name": "Market source", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Ltd appoints Mihir Parikh, Amay Ashok Pandey as Directors", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOd01QQ2VENTFaQTEzWHQxTUZuOHQ0a1RSb2hwNFlVcFF3QnY0MGxkQ1lFczVfZWEzUWFIbE5KOGtiQ3Q1Q1E1SzFuallNSmo1bzVhajNUS3hRb2U2Ujc4SGlSaV9QdHdjcHpoZ01HRC1heXpkelJnNGJYZmI0SXBMMWstaDhpMnp2TTN5YnBCNkQwdUtRYXNPdkZ2bEREaWlXUGpsY0JLRkZHeUhOYXBHSkJlZVhzZ2pVZ2JLNVpkQUJZVlJYNVBGZWNBZHE?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Could Be 20.2% Undervalued After Recent Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOYzJ1VmltcFhibVVwU0stc19wdXd3Z0tKdU1wTUFrcjEzeTI2RnhHc3gxX3YybVZJSVBhQmVreldvLU9SeHVmLTNTTjU0WlpZSDA0aWtzWFhzWW1RS01VYzJTUE5DUDM4RGFtZWFrcWQ1NnFWakZuZUw0VTA4WWFxRWg1X3l0Y2hDZEQ1ZzZNNkFFT1R2ZlYyLVFwUHk?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca (LSE:AZN) Stock Fair Value Edges Lower After Pipeline And Pricing Debate", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNalVkSVBsa1oyTE1DU25VZjlQNWNrWkFTOFRFMEItWjFzaThNMk92WkRydTVCbnBhOFdCUGN0LU1TYUFyd0RfQml6eWdzM1YtV3BGdGZnQ1h6cHlMd1R2U2FtREI4dXhyTktUWW0xNmVXM1lWTzhlN2tleTN2UWktMmNXclE2SWFoT3NZVnh0emctblFYU2c?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQdFRlQ1h2eDM0VHYwa253dVlmYmdfeFBnX2s2VkVtS3RLZU5NZVBsbWs5NDVLaVRFakFhTW91QUVTTU4zM2VYSjc0Q0Exc191TGZoM0xsVnlYaGZUTzZIR0hmZmFlUU1VdFdZejR5TXdoRklwVFlLZnlSeG9Xa1ZiT1pYekZKX2pnX011MzAzS0R2ekpVaW83empGb045NUFLU0E?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxONEc1MDVPTEd1SEt4ZHZxVUlPYWpjcFRBbUY1V2hOZzk5VVZyU09TTjdFQjdDSGhzV1pTTHl3TVloOXJSWC1VTUJSUEFnY0gtdThNQk9BRXgzUEZJZWZKOFhDLWJ5c3N0bkczZUVteGtGeWVFQXNvcjgzeks5MkFQY2pMbHgzbEVCQmk0eWozMjZaOE1ibkE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India closes trading window until Q1FY27 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOWHRfMy01M3lCUkQ5UE5jakFzbFEwZVZGUGdMSDdCc1VCeWdsQ19PcElPREJadmJfT1c1cGZHa1V3ekZoQnpCMGx0aTNKR1A2NFE5SGJnTGR0QWJVUnlvNHoyUkRkWk8za3hqdHl3VzRaOTlhU1BhblNucDFSRjhZUzY3UHFiTGRXTTdRdUtTclhGZlBweUdUNlZXRk5jTVhCdFo3WDVFbUNRS2NiQmtmd3lhc1RYVXFVc1ozZmlB?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India accepts resignations of two senior executives", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZU10dnA0b1luaVA4NGRQMkZZSk1QRFVKQjJzUmxob29XaWFBQ0lGOEtqeWdHOXRDdUpCOGVaVUNKQmR6OWNURGpuTXpiUU1idzg5SHlud0FudEk0djk2V1VqR0pWNXRnVFZ2d2E5RzBWazM3S2l2UkVOQVYyYWx3d0xyN29hQktBMXdDaTh1UzZOQ0dDZ0s2YzhBUHNZcGRXMU5OckVMb05WdnpVN2ZpMnJHVWFHU1BvMzZDNQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think That There Are Issues Underlying AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxPckdQVjl4bG42U2pRdHVXRk5mOFVNODdOS3puV2RkRElnQlJ1VTRFWlpkdjBTSElxcmI0dkZucVBQVnR5SjhKWDNJLW5CT3dKczFOSnBCdlNVb0k3dFJxaUJpZzFMem0tb2RqdFJncFUtMzJKdm55RWc0ZWJOTERLY0hBMU1DXy1sY28xX3FSQWVCQVZWY0xOT2EzU0tWM1BCLU5JNWFwaHhSZGk5RU1lY0hDN3l5RzVISnVTTVlIT2RjTW05dzFReGdUQ2VrbnhGS3NyTmFEMkdycjJNVEN0RUk5V2pPYTFfUXdZNWpJTFlucFMzNzl0MHFn0gH_AUFVX3lxTE1wOUZTQS1JQ2dFbUhoQ3o3ZUJSbU4yZ2FFT19Qb183RWFiTnNUYXVzRy1QWVZoREY1OXhhTEcwaktWcXZCRmRDcHhGNDIzajlXblgtTGlFQmlDSjlLbk9qemQzemkwa0FqN0FKajUwRFNBSW1QZndZZzYtRW94enVBVEZ3X3FfS2NNcWlPa0ZJaFhQenZ3M3JnSy1Xbk9SUXBCME4xSVJ6bHphMWFDc08wYW5BWW5oUmVyWnUzWmZTQWVxMnh0M3ljbGFWWl94WjdON0hmM21zaVlOampyMHZuSG84VnhNSi1LTXRwVUdYcFZGLXF3V0x0QVlIVU9BMA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why AstraZeneca Pharma India (NSE:ASTRAZEN) Has Caught The Eye Of Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQTGNrV3lfQlduQ1N6VjNhNndNV3owT0V5d0dISE4wMi1PRDNMSDEydnZMRGRPWkV6Um5PZkh2dE8xcExzZi1GS3doZXIwTnlEU01jSTJRWXBzTERhcWFrdDd3TkdmT3BRekMwQUdSWlUtak5ybnJ6ZkRNeHBOdXVpdW9DNjktcmJtdWxzRGsyVnp6U1J1WmdSOU15LUJrNEtzR3o0NXBNcWtPeURucmkyQ3NlQmlwN1A5M1VENmxZSk9NYnFyN3FlNUNuWU5iR3FxUXhTWWdCc1kxMXE2M0x4UkVtNzgtd3RHVk1USzFDXzR3ZDRPZEFqNFB30gH_AUFVX3lxTFBHWTlNOXFtSHMwelZsVW1GY0gyQkdWenpEU1ZWNjFSbFdDbUhIa1IyQUNEQW80XzJCTWR4N2p3VmhIaV9ScE5YeFRoUmtVU3dmeWRBWTlGdHo5WG1Od1ZTS3RIeHY0dHVWUnpEb1dYeVlYR2lHRDl2aTFxQmVBQk5RYnRZZ3dSRFR4YnNTXzVsZjFnMWlvNnB4T1BvbUNjQl9fbHhoaktCR0w2bVVILS0wVmo2QXI1V1ZpTnktV2w4UmVZLTNiV2ZOMHhaRG9FcG9zN3JiN2ZuY1R6cGVkZ1NaWnMzREs5UW5QeGtlTExCa2thcmpwRWgtQnJpYzRNOA?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca Pharma Q4 Profit Drops 23% to \u20b944.9 Cr as Margins Shrink to 10.5%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPdDFaMkVFX1JSVUpzX2hVV3N2NF9aU0QzdnQxV3RVRHREa18tX0dFRFQ2THBQQ1cwN0ZqalZ1SjUxdHpTbGVrOHEwaGp4SENGd2xjbExjNmVSVGJNS3BuOWFHbXQ0bGZTTjg3RjJNTFRTa2FIVklqWkhhc2w4NmVxLXB4cmNGa1FoellFZThVa28zNVEzTFpiYnRMZUlneExDeHhkcEs4YjloVVFMblUwTmpOQQ?oc=5", "source_name": "Sahi", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Falls 7% on Q4 Profit Drop, Margin Hit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQVlhlWnZzS29hU1NLQy12MGJBQy1kRHRjYVRQaEhQeFdrTkJMVjBtcjJiSGZwSDBQQVVyY0FFd0xNOEdBS3M0NUI3alhwT01qY0s2QkVER3VPODR3S1JiTEk1TFJMSm9uT2hkQ2ViaUsteDE1YU1Zd1BveGp0VEI1eU95bHpDUmxtR1ZZM3pOblV1SktDODVTTFQ3N1pvcUhwR251Y0t1MVZqOXZqczdFSmowVDRkTS1sdElv?oc=5", "source_name": "HDFC Sky", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma shares slip 6% on posting 23% fall in Q4 profit YoY", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca FY26 revenue rises 33%, recommends \u20b936 dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZW9SampvTEloa2praHBzVWtjWUJtZG9iUkhlcV9yMENENzhKMXl4UjYwdnFDaTM2aURXMGRlOHFyOEFjcXRaS3dtWWdBbl83MDRSdklVZDhoSmxVc0ZzblN5ZTM2NWFiQjVpeFpZamxlT2tHR21BZEdFcUl6eDhLOERodHlCdElJQVRwemQ0bzRKRnhueFBGaHVJNzhFNjBDcUxOb0lyVnZJODdlWEYzTGxLSGhtbGsx?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca falls 7% as Q4 net profit declines 23%; here's a trading strategy for the pharma stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxOeUtEaUU0RzExRkt4blkxVEExNGlmMkduOWJNblZFaHZKeVF3bXFUV1BkcjlhOWNxbVNmN0ZlN0gzalMybkZZb2pHNVVzQ1BJZW1NbkdzMEN1NUhyVDFUZzVuZlJpbkhVaVJJLUVzNmhWYkNmLXRlaktKMThjZHV3b0pPQ00tY1BLUnZUYU1tVFREZzQweGNpQkxhcDNKZElCbGF2RzI2ZXBfeHZtVnBwY01ZZmI1Q284V3pONHNiejRudHY5TS1RRzFyWWthWElvZjZWUmhsZVlfUUI5QTZmNldMRDRObi1sT2RhTnExaUR6UdIB9wFBVV95cUxPVU1Sc0FaM0piVU5yUmFDSUJIYkctMXNFNUxHRWotSDQzRjEzd2JueVpMelZNdHg4ZFpjUmp1U0dYM1JtaUQ5MDZOYkxVVVoteVhPVkFHQU1QRlZoaTViSGhXVEF4cUhVQjNQNFVPYmZIMkktQ2Eyc0EtZmxvd0JyWktydWNUTmFsd3pQWTUyc2tEVDNudFB0aGJ5TzFGcjVwSkl3WXVaSGR3UGdRX0ZtZjhPaEZvbTRvTk5UUTFfa1NPNGcxSkgxMHY0eEhpSjdzdHRPX0tneFB5TndIRXVsM1hubE9BYXlRekdlaDc4U09tNzM5ZWRn?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Q4 profit drops 23% despite strong revenue growth", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma Q4 Profit Drops 23% to \u20b944.9 Cr Despite 20.8% Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPQkxVUlF6bXljMkpqWTdhOHRUWEQtNTI2TGdmU2tjTVdwRXpsNFRLcFRmMEZuUHlEZWpvQTNCaWtUT3lfWWh4enM1V2U5TDVZZ2VNcVRYS3RVZHMyYkhYMzV6SHhaek9qMmVmUC1lYjRWV1FiRWVlZDR3OHpadjhXRlNNbUg3dmVWOUVXU0FxOTJJdE1nUVlSUHJhUWpQS3JQUUtFSXB0Q1lMOUVLclU4YlZJWDc?oc=5", "source_name": "Sahi", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India's Revenue Boost Amid Profit Dip", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQeXpwT1k0OWI4WngzTUF6Sjc3eTY3TTRaWG5MLTNacWVRTGtIX0JvQ2pCbEEtQ3R2Njg1WDJzcGhQM2o2OUNHeXMxRmpfSkF3MjhZVmVvOS1tYUlQMC1BWXhkNVZYaEpRdWI2MXdpRUhVOWZCY2EyWnNMcVBEUzlxZVlVWUtwMXNmLWc0V0lfZnNBSVlUWjdqT1A2THpJSi00SHVZWUh0RndBOWvSAbABQVVfeXFMT2huRDZRRHd4eEx5ci1LUGlIdUozTk8zMU9RZkt1Y2swektfcjVjLTNBOGh2Y3lDbWRKZEpZYjJuRDVGM214NkpXeGF6OFItZHJBQ2RUNGt5SHNPb0R1djBNOVVzZHhOWHhsVGp0VG5wQl9oTl9aSmswbGtFT2xfaC1fWUZyeThRY01KRmt4TkRzLTNlUmdKYjNpTHdwaml3NlBhUnZiZ1BuYWRuNk1Jblk?oc=5", "source_name": "Devdiscourse", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxNcVlCdldmODQxWWs3ZWtFS3JLTWNkZjNoNDh5M0VqZ3RzcFp2YkhzaUpDLWVyWkltTklKMnZVQ0JDeXFkeDBnYUJ0eFRmc2FPRktOc3lTdGd1dDh4UXZzakU4djBGRlZIUm8zYXNOdmdiOFJNQ3MwT3JEbGZod0M0ajdKZW5iSHc3S010YUF3MDlGNGdPajJhNGtoeGJhQm50VV8zYWhNWnRVQkRpVXFzRWowMGQ3NG1teUJjTTFhTDhNVldJNG9qQUlNZF9GX1NnekVVdUJIRXg3RmdaT01WYjdQYUNRWEszd1hzdjFOTQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca stock falls after FDA panel votes against new cancer drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNYWQ4cWdTbU1Bekl1LVhWZjMtSjZFY2N3OGk1YlRzaXZiUkI1TVlJNm85Uk9iY0N2WmFwQkZiVW9aTEc0ZHhhUkRQalhkZ3ViNWx5TWhQcjNyMVpIWWJpNWlOb1Y2dUJRQTBQOXFsaVVNc3ljVC15ZnZzZVlFTWxUMnh0VGpXQdIBiwFBVV95cUxOb2JzdjJacWh4bE9nalhqcDJtNlVpVW1SZ1p2djJoSWt5NG8ycjhLejZOVmZPR1JmejJ3RjF4eUNIQ2c3STRZNFRuNTBFTktPOFpRMEREY2ZmT3I5aVZTSW9jOXVpOUtlWmczTmVYc3ZVM0hoakYwOHpSRldjRXBOMFdlRHBINVpxMC1F?oc=5", "source_name": "CNBC", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch Today: Swiggy, Enviro Infra, Advait Energy, AstraZeneca, Torrent Pharma, Laxmi Organic,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) market cap surged \u20b98.0b last week, public companies who have a lot riding on the company were rewarded", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOdjRreUE2U1VSSEQ0VEprY25EM0pqX001Rm5IUmpaQ0tmdmVrcFNlbEJ4M1ppY0Q1Y1RIQ0k0VlI4YWhFREtJdnJCV25mUzlFYlhDeTNIUFNEYldJSTUyZzh4UXdTdFhRNGhyWHpEMmVndzRMXzRaaGhTWG5oZzdBMFNNLTVFUUo4UVlUX29YTVRRbkdJeDVUT1RZTjFLYVRxVHZfdlVmeFVlV2tiNGRyUEZvbkliQWhITkNvcDhYMXV4MnFYcXN6UGt1QUVWcHZQS0t4ZXNkbTVSVm84WnJXOFRBcW9uNmJJclJ4c3RMTTFZNWZjU05RZExn0gH_AUFVX3lxTE9BWGI2dlEyb1dESVh5S3g2cDV3R2FoNG9SdUs4LXc1YkVoX2gtTnhfTEEwdGc0OE5taUN1MHRpYUl0ajN4LUVtY0o5UUI0OE13T2hib2pidVRSeWs5aVNVTG9hbW5CRXBhQkZ5OExxbVE1QWFNVjdfTTh5T0NhRDEzWkpwTDlMd3I5QV9qNG10RGVCako5dThFaWxScUJ4VE8zN1hDNFp0MDA1aWFodXV2S3lGQ2xfMVZHTkJCY0hNT2VzWDNtUUFhV0tjZ1l1Wm5Qc0dFQTVUbmdwaTBLLUhVTmowYW5qQ0ViV0RVLVBFTmVwaV9ySnRxUjJNeURzdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-16T08:00:00+00:00", "published_display": "16 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca begins trading on the New York Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPMWtuQzczY3ltajY4cUdBOVJGcEdDcXN1Nk12RVhwWU9MYXFvYzc1ckpZeHB3bnFlQ1A2OG01S3lTUDJqQUdEYUVXS2FpTXBudVdYTC1aX2I0MGRUdVNSMzBJRGZtTnM3YTNXcXp0eEVWaEpJb1E0TTlWY2J5VjNSdWtjQTFIMV8ySENONTJ5MzI2ZHVvLWFjaUtpejRacWxELXc?oc=5", "source_name": "AstraZeneca", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India Ltd. Share Price Today - AstraZeneca Pharma India Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOLUNvQmlGQW1rWnlaTzNnSHBkVEF4RFRWZHBPMXR6RzRwOWZNOGRwWDJPcVdhWmo0YzBsZzVPMDdmenpIRkJfWnFKeVV4R0xzMlo4Nlo1cTVzNG50QmpZMWdyTE1hVFZHVndxeXkwX2haX05jT3hFS1Q4RE5lOVdVQjhIc2RLRkVtaDJwQQ?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T08:16:25+00:00", "published_display": "03 Jan 2026 08:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca Pharma India shares surge over 3% on new Hyperkalaemia drug deal with Sun Pharma", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPV2FPR2twQUd0YUpOazQ3TnZEYThGMlhJaHd5SWtvY0RxeEkxUHF6U0lmOU9MbG9Ja255cTdjTjdHb25Ecm9HR3ZINjVmNkYzTktDZnlYWmxMdEFUcFVNdzNXaTB2di1EeXlubGs3LU0tb3hheElMVE84TUg0Q2pEVGVURXYzVDNlZF9majhNbmI1LW0zSTJVVVp1eDdMRkRwVWZHRkp2T09yQUwtRWVsZnppbDRxUUlMTnhCOUxDdnBURXNUSkFDcllEWFBnSHFka2VyRW5EclVyd21QWWg2UnBQc1ktNkI1dk5aLTNxRVBId9IB9wFBVV95cUxPdHQ2bmJZMEFkTXFndWpWN2JZajV6MHhDT1B1a3FObHlhZzZuZ1Z1ejFPMnZlZHdMQ3hHZFNWUkxpM2xWS1pWN21rSVU0Y2dkU1RYQnc4RS1Pc0ZJVVBsX25NbTA3QWFRVW5PUEx0UnlWU2w0Q1lyQmtNaGhyZk1HSWZwaFg1THZIQWJSRmtYcFphQTc3YmdVdVc2QWN3Tm9JQlB5am9qbzg3cmZncWozVk9QaFVzdVJoN3c5LUVhMTRoM3ZJS1E2aE5mZDZIcThQR2YwdUxIS21CYmF4OVRIZ0pwdGh4M0ktM3VZN1N4MzhwTkNWdFB3?oc=5", "source_name": "The Economic Times", "published_at": "2025-11-18T08:00:00+00:00", "published_display": "18 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AstraZeneca, exiting production digs in India, surrenders local manufacturing license", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPd0pNMWRYdGxiaUVDTkpKeDFhbTloLUNvVTVRZVpkMk5TNWpHVFNnSzlZdjRuTDdpSE1oRlVNOEcwVm1fdEFoUXRBYTYwTExQb3AwdzI1d19KM1pCY05qWE1NSWtfVWw4Y080WFZ0Z0JLVmV4RmZyTC1HaTM3b1NlTFVyWFJlSmRGeWZzOHVxTlFfQ0hKX3h4VlA3ZFRWQ1l1OHNNbXAzTjhWOFFzT0M2c2dub0JUdFJKcVJYVWJqQmo?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-09-03T07:00:00+00:00", "published_display": "03 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 40, "sentiment_summary": {"positive": 8, "negative": 8, "neutral": 24, "score": 49, "total": 40, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 18.35, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 6.55, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 0.9, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 8, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 8117.5, "latest_week": "2026-07-10", "one_week_move": -2.3, "four_week_move": -1.6, "twelve_week_move": -4.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.25554, "market_dynamics_buy_signal": false, "relative_strength": -4.455636, "fair_value_gap": 13.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 49.3426, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.3% over one week, -1.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "scanx.trade", "count": 4}, {"label": "CNBC", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "Business Standard", "count": 2}, {"label": "Barron's", "count": 2}, {"label": "Sahi", "count": 2}, {"label": "Moneycontrol.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 40}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "40", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "15", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.3% over one week, -1.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "AstraZeneca Pharma India gets CDSCO nod for additional Fasenra indication"}], "updated_at": "2026-07-17T13:07:43.061596+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}